This global project, led by the International Longevity Centre, brings together the latest evidence on vaccine cost-effectiveness to support decision-making for health and finance leaders.
Health spending at present is binary: Spending on X is a choice not to spend on Y. Therefore, there must be a strong rationale and body of evidence to support dedicating resources to preventative interventions such as vaccination. This project synthesises that evidence and aims to influence G7, G20, World Health Assembly, UN High-Level Meetings, and World Bank/IMF global events to make the case for life course vaccination.
